Details for New Drug Application (NDA): 021887
✉ Email this page to a colleague
The generic ingredient in ALLI is orlistat. There are twelve drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the orlistat profile page.
Summary for 021887
| Tradename: | ALLI |
| Applicant: | Haleon Us Holdings |
| Ingredient: | orlistat |
| Patents: | 0 |
Pharmacology for NDA: 021887
| Mechanism of Action | Lipase Inhibitors |
Suppliers and Packaging for NDA: 021887
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ALLI | orlistat | CAPSULE;ORAL | 021887 | NDA | Haleon US Holdings LLC | 0135-0461 | 0135-0461-01 | 60 CAPSULE in 1 BOTTLE (0135-0461-01) |
| ALLI | orlistat | CAPSULE;ORAL | 021887 | NDA | Haleon US Holdings LLC | 0135-0461 | 0135-0461-02 | 90 CAPSULE in 1 BOTTLE (0135-0461-02) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | CAPSULE;ORAL | Strength | 60MG | ||||
| Approval Date: | Feb 7, 2007 | TE: | RLD: | Yes | |||||
Expired US Patents for NDA 021887
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Haleon Us Holdings | ALLI | orlistat | CAPSULE;ORAL | 021887-001 | Feb 7, 2007 | 4,598,089 | ⤷ Get Started Free |
| Haleon Us Holdings | ALLI | orlistat | CAPSULE;ORAL | 021887-001 | Feb 7, 2007 | 6,004,996 | ⤷ Get Started Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
